Epidemiology of cardiovascular disease in chronic renal disease - PubMed (original) (raw)
Review
. 1998 Dec;9(12 Suppl):S16-23.
Affiliations
- PMID: 11443763
Review
Epidemiology of cardiovascular disease in chronic renal disease
R N Foley et al. J Am Soc Nephrol. 1998 Dec.
Abstract
The risk of cardiovascular disease in patients with chronic renal disease appears to be far greater than in the general population. For example, among patients treated by hemodialysis or peritoneal dialysis, the prevalence of coronary artery disease is approximately 40% and the prevalence of left ventricular hypertrophy is approximately 75%. Cardiovascular mortality has been estimated to be approximately 9% per year. Even after stratification by age, gender, race, and the presence or absence of diabetes, cardiovascular mortality in dialysis patients is 10 to 20 times higher than in the general population. Patients with chronic renal disease should be considered in the highest risk group for subsequent cardiovascular events. Cardiac failure is more common in chronic renal disease patients than in the general population, and is an independent predictor of death in chronic renal disease. Among hemodialysis and peritoneal dialysis patients, the prevalence of cardiac failure is approximately 40%. Both coronary artery disease and left ventricular hypertrophy are risk factors for the development of cardiac failure. In practice, it is difficult to determine whether cardiac failure reflects left ventricular dysfunction or extracellular fluid volume overload. Patients who develop clinical manifestations of cardiac failure should be evaluated for cardiovascular disease.
Similar articles
- [Cardiovascular risk in patients with chronic renal failure. Patients in renal replacement therapy].
Cases A, Vera M, López Gómez JM. Cases A, et al. Nefrologia. 2002;22 Suppl 1:68-74. Nefrologia. 2002. PMID: 11987673 Review. Spanish. - Epidemiology of cardiovascular risk factors in chronic renal disease.
Coresh J, Longenecker JC, Miller ER 3rd, Young HJ, Klag MJ. Coresh J, et al. J Am Soc Nephrol. 1998 Dec;9(12 Suppl):S24-30. J Am Soc Nephrol. 1998. PMID: 11443765 Review. - [Cardioprotection: an essential component for predialysis chronic renal failure treatment].
Jungers P, Qualim Z, Nguyen-Khoa T, Massy Z, London G. Jungers P, et al. Nephrologie. 2003;24(2):79-88. Nephrologie. 2003. PMID: 12723513 Review. French. - [Cardiovascular disease in Chinese chronic renal insufficiency patients-epidemiology survey].
Hou FF, Ma ZG, Mei CL, Rong S, Huang SM, Liu XR, Yuan WJ, Guo YS, Wang L, He Q, Wang XL, Sang XH, Li XL. Hou FF, et al. Zhonghua Yi Xue Za Zhi. 2005 Feb 23;85(7):458-63. Zhonghua Yi Xue Za Zhi. 2005. PMID: 15854551 Chinese. - Cardiovascular disease in the dialysis population: prognostic significance of arterial disorders.
Guérin AP, Pannier B, Marchais SJ, London GM. Guérin AP, et al. Curr Opin Nephrol Hypertens. 2006 Mar;15(2):105-10. doi: 10.1097/01.mnh.0000203186.11772.21. Curr Opin Nephrol Hypertens. 2006. PMID: 16481874 Review.
Cited by
- Hemoincompatibility in Hemodialysis-Related Therapies and Their Health Economic Perspectives.
Hornig C, Bowry SK, Kircelli F, Kendzia D, Apel C, Canaud B. Hornig C, et al. J Clin Med. 2024 Oct 16;13(20):6165. doi: 10.3390/jcm13206165. J Clin Med. 2024. PMID: 39458115 Free PMC article. - β-blockers in hemodialysis: simple questions, complicated answers.
Hundemer GL, Sood MM, Canney M. Hundemer GL, et al. Clin Kidney J. 2020 Dec 22;14(3):731-734. doi: 10.1093/ckj/sfaa249. eCollection 2021 Mar. Clin Kidney J. 2020. PMID: 33779640 Free PMC article. - High-Volume Hemodiafiltration and Cool Hemodialysis Have a Beneficial Effect on Intradialytic Hemodynamics: A Randomized Cross-Over Trial of Four Intermittent Dialysis Strategies.
Rootjes PA, Chaara S, de Roij van Zuijdewijn CLM, Nubé MJ, Wijngaarden G, Grooteman MPC. Rootjes PA, et al. Kidney Int Rep. 2022 Jul 14;7(9):1980-1990. doi: 10.1016/j.ekir.2022.06.021. eCollection 2022 Sep. Kidney Int Rep. 2022. PMID: 36090495 Free PMC article. - High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients.
Maduell F, Moreso F, Pons M, Ramos R, Mora-Macià J, Carreras J, Soler J, Torres F, Campistol JM, Martinez-Castelao A; ESHOL Study Group. Maduell F, et al. J Am Soc Nephrol. 2013 Feb;24(3):487-97. doi: 10.1681/ASN.2012080875. Epub 2013 Feb 14. J Am Soc Nephrol. 2013. PMID: 23411788 Free PMC article. Clinical Trial. - Impact of physical activity on surrogate markers of cardiovascular disease in the haemodialysis population.
Hull KL, Abell L, Adenwalla SF, Billany RE, Burns S, Burton JO, Churchward D, Graham-Brown MPM, Gray LJ, Highton P, Lightfoot CJ, Said R, Smith AC, Young HML, March DS. Hull KL, et al. Clin Kidney J. 2024 Jun 28;17(7):sfae198. doi: 10.1093/ckj/sfae198. eCollection 2024 Jul. Clin Kidney J. 2024. PMID: 39050864 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical